Published in Women's Health Weekly, January 20th, 2005
The ALMANAC trial is a large, randomized, multicenter trial in the United Kingdom designed to quantitatively assess the effectiveness and morbidity of sentinel node biopsy in patients with clinically node-negative invasive breast cancer and compare it to standard axillary dissection.
Standard axillary dissection has long been the standard...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.